Our Medical Experts
Max Healthcare is home to 4800+ eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
Find a Doctor
Musculoskeletal Oncology
Overview
Musculoskeletal / Orthopaedic Oncology Disease Management Group (DMG) at Max Institute of Cancer Care comprises of a dedicated group of specialists whose focus is to provide a comprehensive management to all patients presenting with benign and malignant tumors of bones and soft tissues. It is now established beyond doubt that multidisciplinary involvement is essential for an optimal outcome of the management of these rare diseases, and we at Max Institute of Cancer Care (MICC) boast of a team of experienced doctors specialized in the care of patients with bone and soft tissue tumors. This team consists of orthopaedic, surgical, medical, and radiations oncologists, pathologists, radiologists, physiotherapists, onco-psychologists, nuclear medicine specialists, and molecular oncologists.
Treatment of each musculoskeletal cancer patient needs to individualized planning and personalization. At Max Institute of Cancer Care, all such cases are taken up in a multidisciplinary Tumour board where specialists from the field of orthopaedic oncology, surgical oncology, radiation oncology, medical oncology, radiology and pathology discuss each case threadbare and come up with a treatment regimen that not only maximizes survival but also ensures good functional outcomes.
WHAT WE DO
Surgical Oncology:
Surgical management of all malignant and benign bone and soft tissue tumours
- Limb salvage surgery for malignant bone tumours (osteosarcoma, Ewing sarcoma, chondrosarcoma, and others) - use of the prosthesis, bone grafts, extracorporeal radiation (ECRT), cryosurgery, etc.
- Precision bone tumour removal using modern imaging ensuring complete tumor removal and maximizing form and function.
- Limb salvage surgery for soft tissue sarcomas
- Curettage for benign bone tumours (Giant cell tumours, chondroblastoma, osteoblastomaetc)
- Non-surgical management like sclerotherapy and radiofrequency ablation of benign bone tumorseg. (Aneurysmal bone cysts, simple bone cysts, osteoid osteoma etc.)
- Management of metastatic bone disease , ie involvement of bone due to spread of cancer cells from other organs like lung / breast/ prostate cancer etc. Therapeutic and prophylactic fixations with adjuvant helps to achieve early mobilisation.
- Spine tumors – primary or metastatic tumors are treated with decompression, stabilisation. Minimally invasive technique like vertebroplasty, ballon kyphoplasty, can be done.
Medical Oncology:
- Chemotherapy for bone and soft tissue sarcomas include modern protocols accepted worldwide
- Expertise in NeoAdjuvant and Adjuvant Chemotherapy for paediatric and adult bone and soft tissue sarcomas
- Palliative chemotherapy/ targeted therapy for advanced stage diseases
- High Dose Chemotherapy with Stem Cell Transplantation in appropriate cases
- Exclusive paediatric oncology unit for chemotherapy of children with sarcomas
- Focus on maximizing survival with preservation of organ and function
- Expert pathology and radiology inputs with clinical correlation through Orth- Radio Patho meets for optimum diagnosis and treatment
- An ethos of personalized evidence-based care with an emphasis on solutions optimized for each individual patient
- Weekly DMG (Disease Management Group) clinic and musculoskeletal tumour board
Radiation Oncology:
- Radiation Therapy (RT) for bone and soft tissue tumors
- Radiation Therapy for bone as well as soft tissue sarcomas is done in definitive, pr- op, Intra op (During surgery) and post operation as required for a given case
- For bone tumors like Ewing's sarcoma, we do high dose precision radiation therapy (with high doses ) with or without surgery as per indication
- Peri-operative interstitial brachytherapy: In soft tissue sarcomas as much as possible we do interstitial brachytherapy with brachytherapy catheter placement in tumour bed at the time of surgery and treatment in immediate postoperative phase. It gives high doses of radiation therapy with less side effects and avoidance of long duration RT after surgery.
- Extra Corporeal RT (ECRT)- In some limb tumoursit’s possible to surgically remove tumours bone and take this bone out of a body and give it a single shot of high dose radiation therapy (while bone is outside patients body). This bone is then put back in patient’s body. This is called extracorporeal radiation therapy. Purpose of this high dose radiation is that all tumour cells and normal bone cells get killed by high dose radiation therapy and this bone segment can be used as a customized prosthesis for the patient. Since Radiation therapy is given to bone outside the patient’s body, there is no impact of RT on the patient.
- Pre-op Radiation therapy
- We also practice preoperative Radiation therapy (in place of postoperative RT) whenever indicated in any soft tissue or a bone tumour with the idea of shrinking tumour for the better surgical outcome and decrease late side effects of postoperative radiation therapy.
- Precision Radiation therapy
- At Max Institure of Cancer Care (MICC), we practice Radiation therapy using focused techniques like 3DCRT, Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT). These techniques help us significantly reduce immediately and delayed adverse effects of treatment.
- For treating metastases form bone and soft tissue sarcomas we practice Stereotactic Body Radiation therapy (SBRT)- which deposits high radiation dose with minimal dose to surrounding organs
FAQs
1. What are the common types of musculoskeletal tumours?
Ans: Common types of musculoskeletal tumours include osteosarcoma, chondrosarcoma, Ewing's sarcoma, giant cell tumour, malignant fibrous histiocytoma, and chordoma.
2. How does surgery help in the treatment of musculoskeletal oncology?
Ans: Surgery is the primary treatment for musculoskeletal oncology. It involves the removal of the affected bone or tissue and, in some cases, reconstruction using prosthetics or bone grafts.
3. Can muscle cancer spread?
Ans: Sarcoma cells can invade different areas of the body. For example, sarcoma cells in arm muscles can spread to the lungs and develop there. This process is known as metastasis.
4. Can musculoskeletal oncology recur after treatment?
Ans: Musculoskeletal oncology can recur after treatment, although the risk of recurrence is generally low. Close monitoring and follow-up care are crucial to detect any potential recurrence early.
5. What are the side effects of musculoskeletal oncology treatment?
Ans: Side effects of musculoskeletal oncology treatment may include pain, fatigue, nausea, hair loss, skin irritation, and decreased immune function.
Review
FAQs reviewed by Dr. Akshay Tiwari, Director & Head, Musculoskeletal Oncology.
Musculoskeletal Oncology explained
Musculoskeletal Oncology explained
Associate Director & Head - Musculoskeletal Oncology Cancer Care/Oncology, Musculoskeletal Oncology, Paediatric (Ped) Oncology, Surgical Oncology , Musculoskeletal Surgical Oncology
Tumor Board Timings
Musculoskeletal - Wednesday 3:00 pm - 4:00 pm
Central Tumour Board - Monday 8:30 - 9:30 AM
Central Tumour Board - Friday 8:30 - 9:30 AM
Musculoskeletal - Wednesday 3:00 pm - 4:00 pm
Central Tumour Board - Monday 8:30 - 9:30 AM
Central Tumour Board - Friday 8:30 - 9:30 AM
Central Tumour Board - Friday 4:00 pm - 5:00 pm
Central Tumour Board - Friday 4:00 pm - 5:00 pm
Central Tumor Board - Monday & Thursday 8:30am-9:30am
Virtual Tumour Board PAN INDIA - Wednesday 3:00 PM - 4:00 pm
Virtual Tumour Board PAN INDIA - Saturday 9:00 AM - 12:00 AM
Get Second Opinion
Our Medical Experts
Max Healthcare is home to 4800+ eminent doctors in the world, most of whom are pioneers in their respective fields. Additionally, they are renowned for developing innovative and revolutionary clinical procedures.
